Complement receptor 3 (CR3)-dependent microglial synapse elimination drives Parkinson's disease pathogenesis in...

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Systemic inflammation is linked to Parkinson's disease (PD) pathogenesis.
• The precise mechanisms driving PD progression due to systemic inflammation are not fully understood.

Purpose of the Study:

• To investigate the pathological events in a mouse model of systemic inflammation-induced PD.
• To elucidate the role of microglia and synaptic changes in early PD development.

Main Methods:

• Utilized a lipopolysaccharide (LPS)-induced systemic inflammation mouse model.
• Monitored synaptic loss, dopaminergic (DA) neuron degeneration, and microglial activation over time.
• Investigated the role of complement receptor 3 (CR3) in microglial synaptic engulfment.

Main Results:

• Synaptic loss in the midbrain occurred rapidly (1 day post-LPS), preceding DA neuron degeneration (14 days post-LPS).
• Early microglial activation and excessive synaptic engulfment were observed.
• Inhibition of CR3 prevented synaptic loss and neurodegeneration.

Conclusions:

• Microglia-dependent synapse elimination is a critical early event in PD pathogenesis driven by systemic inflammation.
• CR3 is a key mediator of this microglial synaptic engulfment.
• Targeting microglial complement signaling presents a promising early intervention strategy for PD.